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Summary
 
A subset of CD4
 
1
 
CD11c
 
2
 
CD3
 
2
 
 blood cells was recently shown to develop into dendritic cells
when cultured with monocyte conditioned medium. Here, we demonstrate that CD4
 
1
 
CD11c
 
2
 
CD3
 
2
 
 cells, isolated from tonsils, correspond to the so-called plasmacytoid T cells, an
obscure cell type that has long been observed by pathologists within secondary lymphoid tis-
sues. They express CD45RA, but not markers specific for known lymphoid- or myeloid-derived
cell types. They undergo rapid apoptosis in culture, unless rescued by IL-3. Further addition of
CD40-ligand results in their differentiation into dendritic cells that express low levels of mye-
loid antigens CD13 and CD33.
 
B
 
and T lymphocytes share many similarities, including
their developmental programmes, the structures of
their antigen receptors, and the requirement for costimula-
tory molecules for activation. B lymphocytes will finally
differentiate into plasma cells that secrete antibody, the key
effector molecule of humoral immune responses. Interest-
ingly, pathologists have long observed the presence of
plasma cells that express the T cell marker CD4 and lack
intracellular immunoglobulins within the T cell zones of
human lymph nodes (1–3). These plasma cells were sug-
gested to represent terminally differentiated T plasma cells
of unknown secretory functions. Paradoxically, these so
called plasmacytoid T cells were found not to express other
T cell markers such as CD3 and TCRs (4, 5). They ex-
pressed MHC class II antigens, HLADR and HLADQ, and
the invariant chain CD74 (6, 7).
The CD4
 
1
 
 plasmacytoid cells were also found in human
spleen and thymus from patients with myasthenia gravis
(5). These cells were found in increased number in lymph
nodes taken from patients suffering from lymphomas, leu-
kemias (8), patients with breast cancer metastases (4), and
lymphadenitis (5). In addition, cases of plasmacytoid T cell
lymphomas were reported that paradoxically evolved to-
wards myelomonocytic leukemia (9). These data suggest
that the CD4
 
1
 
 plasmacytoid cells represent a neglected but
important cell type of the immune system. However, the
nature and the fate of these plasmacytoid cells has remained
unknown.
Here, we report the isolation of plasmacytoid cells from
human tonsils. The phenotypical, anatomical and func-
tional characterization indicates that these cells correspond
to the CD4
 
1
 
CD11c
 
2
 
 blood dendritic cell (DC)
 
1
 
 presursors,
that either undergo rapid apoptosis or differentiate into DC
upon culture with IL-3 and CD40-ligand.
 
Materials and Methods
 
Immunohistological Localization of CD4
 
1
 
CD11c
 
2
 
CD3
 
2
 
 Cells.
 
Double stainings on human tonsil sections were performed using
mouse IgG1 anti-CD3 (Immunotech, Marseille, France) and anti-
CD11c (Dako, Glostrup, Denmark) together with mouse IgG2a
anti-CD4 (Innotest, Besancon, France). The binding of mouse IgG1
antibodies was revealed by sheep anti–mouse IgG1 (The Binding
Site, Birmingham, UK), followed by mouse anti-alkaline phos-
phatase-alkaline phosphatase complexes (Dako), the APAAP tech-
nique. The binding of mouse IgG2a antibodies was revealed by
sheep anti–mouse IgG2a-biotin (The Binding Site), followed by
ExtrAvidin-peroxidase (Sigma Chem. Co., St. Louis, MO). Alka-
line phosphatase activity was developed by the Fast Blue sub-
strate, whereas peroxidase activity was developed by 3-amino-
ethylcarbazole.
 
Purification of CD4
 
1
 
CD11c
 
2
 
 Lin
 
2
 
 Cells.
 
CD4
 
1
 
CD11c
 
2
 
 cells
were isolated from human tonsils. In brief, tonsils were cut into
small pieces and digested for 12 min at 37
 
8
 
C with collagenase IV
(1 mg/ml; Sigma) and deoxyribonuclease I (50 KU/ml, Sigma) in
RPMI 1640. The cells, pooled from two rounds of tissue diges-
tion, were centrifuged over 50% Percoll (Pharmacia, Uppsala,
Sweden) for 20 min at 400 
 
g.
 
 CD3
 
1
 
 T cells, CD14
 
1
 
 monocytes,
CD19
 
1
 
 and CD20
 
1
 
 B cells, and CD56
 
1
 
 NK cells were depleted
 
1
 
Abbreviations used in this paper:
 
 DC, dendritic cell; GCDC, dendritic cells
within germinal centers; HEV, high endothelial veinules; RER, rough
endoplasmic reticulum; SEM, scanning electron microscopy; TEM, trans-
mission electron microscopy.
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Figure 1. Anatomical localization of CD41CD11c2CD32 plasmacytoid cells. To distinguish CD41CD11c2CD32 plasmacytoid cells from
CD41CD31 T cells and CD41CD11c1 germinal center dendritic cells, double staining with anti-CD3 (blue), anti-CD11c (blue), and anti-CD4 (red) on
tonsillar sections was performed. Accordingly, whereas CD41CD31 T cells and CD41CD11c1 germinal center dendritic cells should be double stained
purple, CD41CD11c2CD32 plasmacytoid cells should be single stained red. (A) shows a germinal center and its adjacent T cell–rich extrafollicular areas
containing HEV. Red CD41CD11c2CD32 plasmacytoid cells can only be found in T cell area but not in germinal center. (B) shows that the same ger-
minal center displayed in A does not contain red CD41CD11c2CD32 plasmacytoid cells. (C) shows that the same T cell area displayed in A contains
many red CD41CD11c2CD32 plasmacytoid cells, located within or around HEV. (D) shows a red CD41 CD11c2CD32 plasmacytoid cell within the
lumen of HEV. (E) shows many red CD41CD11c2CD32 plasmacytoid cells, one in particular is within the endothelial wall of HEV. Original magnifi-
cation: (A) 3100; (B, C) 3200; (D, E) 3400. 
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from the resulting low density cells by immunomagnetic beads
(sheep anti–mouse Ig–coated Dynabeads; Dynal, Oslo, Norway).
The resulting cells were stained with mouse anti–CD4-PE-Cy5
(Immunotech), anti–CD11c-PE (Becton Dickinson), and a cock-
tail of FITC-labeled mAbs anti-CD3 and anti-CD34 (Immuno-
tech), anti-CD20, anti-CD57, anti-CD7, anti-CD14, and anti-
CD16 (Becton Dickinson), and anti-CD1a (Ortho). Then CD4
 
1
 
CD11c
 
2 
 
Lin
 
2
 
 cells were isolated by cell sorting. Reanalysis of the
sorted cells confirmed a purity of 98%.
 
Purification of Naive T Cells from Adult Blood.
 
CD4
 
1
 
CD45RA
 
1
 
T cells were purified from blood mononuclear cells by immu-
nomagnetic bead depletion using a cocktail of mAbs IOM2
(CD14), ION16 (CD16), ION2 (HLA DR) (Immunotech),
NKH1 (CD56), OKT8 (CD8) (Ortho), 4G7 (CD19), UCHL1
(CD45RO), and mAb 89 (CD40). After three rounds of bead de-
pletion, purity of CD4
 
1
 
 T cells was routinely 
 
>
 
96%.
 
FACS
 
Ò
 
 Analysis of CD4
 
1
 
CD11c
 
2
 
 Cocktail FITC
 
2
 
-sorted
Cells.
 
FITC-labeled mAbs for surface phenotyping of sorted (or
cultured) cells were purchased from Immunotech (CD13, CD33,
CD34, CD8, CD11b, CD21, CD18, CD54, CD58, and CD38),
Becton-Dickinson (CD14, CD2, TCR 
 
ab
 
, MHC class II DR
and DQ, CD16, and CD71), Coulter (TCR-
 
gd
 
), Sigma (CD45,
CD44), Dako (CD45RO, CD23, CD11a, and CD11c), Phar-
Mingen (CD35), Medarex (CD32). PE-labeled mAbs were pur-
chased from Becton Dickinson (CD80), Immunotech (CD40), and
PharMingen (CD86). Cells, incubated with antibody for 15 min
at 4
 
8
 
C, were analyzed after one wash with a FACScan
 
Ò
 
 flow cy-
tometer. Negative controls were performed with unrelated mu-
rine mAbs (Dako). These negative controls are indicated by filled
histograms.
 
Proliferation Assays and DC Generation in Culture.
 
CD4
 
1
 
CD11c
 
2
 
Lin
 
2
 
 cells were cultured with IL-3 in the presence or absence of
CD40L fibroblasts (10). All cultures were performed in RPMI
1640 supplemented with 10% of FCS, 2 mM 
 
l
 
-glutamine and
antibiotics. Cells (1.5 
 
3
 
 10
 
4
 
) were seeded in 96-well flat-bottom
microtiter plates for the DNA synthesis assay. After 3 d, cells were
pulsed with 1 
 
m
 
Ci [
 
3
 
H]thymidine for 8 h before harvesting and
counting. Tests were carried out in triplicate and standard devia-
tions are indicated with bars. For viable cell recovery estimation,
cells were counted by Trypan blue dye exclusion. rhIL-3 or GM-
CSF (Schering-Plough Research Institute, Kenilworth, NJ) were
used at a saturating concentration of 10 ng/ml (50 U/ml) and 100
ng/ml (200 U/ml), respectively. rhTNF
 
a
 
 (Genzyme, Boston,
MA) was used at 2.5 ng/ml (50 U/ml). For phenotypic studies, 3 
 
3
 
10
 
5
 
 to 5 
 
3
 
 10
 
5
 
 cells were cultured in 48-well flat-bottom plates (5
CD40L fibroblasts for 1 CD4
 
1
 
CD11c
 
2
 
 cocktail FITC
 
2
 
 cell).
 
T Cell Proliferation Assay.
 
DC (10 to 5,000) were cultured
with 5 
 
3
 
 10
 
4
 
 allogeneic blood CD4
 
1
 
CD45RA
 
1
 
 T cells in
round-bottomed 96-well culture plates in RPMI 1640 containing
10% human AB1 serum. The DC used were generated by culture
of (a) CD41CD11c2Lin2 cells for 6 d in the presence of IL-3
with or without CD40L transfected fibroblasts; (b) blood mono-
cytes for 10 d with GM-CSF plus IL-4 (50 U/ml) (11, 12); and
(c) CD341 cells for 12 d with GM-CSF and TNFa (13). After 5 d
of DC-T cell cocultures, cells were pulsed with 1 mCi [3H]thy-
midine for 8 h before harvesting and counting. Tests were carried
out in triplicate and standard deviations are indicated with bars.
Electron Microscopic Analysis of CD41CD11c2Lin2 Cells. For elec-
tron microscopy, CD41CD11c2Lin2 cells (freshly isolated or cul-
tured cells) were fixed in 2.5% glutaraldehyde plus 0.8% para-
formaldehyde in 0.1 M cacodylate buffer and postfixed with an
aqueous solution of 1% OsO4 containing K4Fe(CN)6. For scan-
ning electron microscopy (SEM), cells were allowed to settle on
coverslips precoated with poly-l-lysine, dehydrated in an acetone
series, dried by the critical point method (CO2), and coated with
10 nm gold in sputter device. Observations were made with a
SEM 505 instrument (Philips, Eindhoven, Netherlands). For
transmission electron microscopy (TEM), the cells were dehy-
drated in an alcohol series and embedded into epon. Ultrathin
sections (z50 nm) were stained with lead citrate and uranyl ace-
tate and studied with a CM 100 instrument (Philips).
Results
Localization and Isolation of Tonsillar Plasmacytoid T
Cells. In previous studies, plasmacytoid T cells in situ
were shown to express CD4 but to lack lineage markers
specific for B cells, T cells, NK cells, monocytes, Langer-
hans cells, and granulocytes (1–7). They expressed CD11a
but not CD11b or CD11c (5). To determine if human ton-
sils contained CD41 plasmacytoid T cells, double staining
with anti-CD3 (blue) plus anti-CD11c (blue) together
with anti-CD4 (red) was performed on tonsil sections. Ac-
cordingly, whereas CD41CD31 helper T cells, CD4low
CD11c1 interdigitating cells and CD41CD11c1 dendritic
cells within germinal centers (GCDC) (14) should be dou-
ble stained purple, CD41CD11c2CD32 plasmacytoid T cells
should be single stained red (Fig. 1). Indeed, red CD41
CD11c2CD32 cells were found in the T cell–rich extrafol-
licular areas (Fig. 1, A, C, D, E) but not within germinal
centers (Fig. 1, A and B), confirming the previous observa-
tions in lymph nodes (5). Interestingly, many red CD41
CD11c2CD32 cells were found to be close to or within
the high endothelial veinules (HEV) (Fig. 1, C, D, E), sug-
gesting that these cells might be blood derived cells that
were crossing the HEV. The CD41CD11c2CD32 cells
within the T cell rich areas indeed displayed a plasmacytoid
morphology (Fig. 1, C, D, E).
According to the in situ phenotype of plasmacytoid T
cells, a multistep isolation method was developed includ-
Figure 2. Cell sorting of CD41CD11c2CD32 plasmacytoid cells. After
preparation of tonsillar cells that are negative for CD3, CD14, CD19,
CD20, and CD56 (detailed in Materials and Methods), cells were stained
with mouse anti–CD4-PE-Cy5 (Immunotech), anti–CD11c-PE (Becton
Dickinson), and a cocktail of FITC-labeled mAbs anti-CD3 and CD34
(Immunotech), anti-CD20, anti-CD57, anti-CD7 and anti-CD16 (Bec-
ton Dickinson), and anti-CD1a (Ortho). As shown in the left panel, cells
were first selected by their cocktail FITC2 (Lin2). This selected popula-
tion contains CD41CD11c1 germinal center dendritic cells (14) and
CD41 CD11c2 plasmacytoid cells, as shown in the right panel.1104 IL-3–dependent Plasmacytoid Dendritic Cell Precursors
ing: (a) centrifugation .50% Percoll; (b) magnetic bead de-
pletion of B cells (CD191CD201), T cells (CD31), mono-
cytes (CD141) and NK cells (CD561); (c) finally sorting for
CD41CD11c2 cells that were negative for CD7, CD57,
CD20, CD3, CD14, CD1a (Langerhans cells), CD34, and
CD16 (Fig. 2). Two CD41Lin2 populations were identi-
fied (Fig. 3 A). The CD41CD11c1 population that repre-
sents GCDCs has been described earlier (14). On Giemsa
staining, freshly sorted CD41CD11c2 cells display a plasma
cell-like morphology, characterized by an eccentric nu-
cleus, a blue basophilic cytoplasm and pale Golgi zone (Fig.
3 A). By scanning electron microscopy, these cells display a
smooth round lymphoid morphology and are 8–10 mm in
diameter (Fig. 3 B). By transmission EM, the cells display
nuclei with marginal heterochromatin and cytoplasm con-
taining juxtanuclear Golgi apparatus and parallel arrays of
rough endoplasmic reticulum (RER) (Fig. 3, C and D).
However, unlike immunoglobulin containing CD3811
Figure 3. Morphology of freshly isolated CD41CD11c2CD32 plasmacytoid cells. (A) Giemsa staining; (B) SEM; (C) TEM; (D) TEM. (E) negative anti-
Ig k1l light chain staining of CD41CD11c2Lin2 plasmacytoid cells; (F) positive anti-Ig k1l light chain staining of CD3811CD202 Ig–secreting
plasma cells. Original magnification: (A, F) 31,000; (B) 33,500; (C) 32,000; (D) 38,000.1105 Grouard et al.
CD202 plasma cells isolated from human tonsils (Fig. 3 F),
these CD41CD11c2Lin2 plasmacytoid cells did not con-
tain intracellular immunoglobulin (Fig. 3 E).
The Phenotype of Isolated CD41CD11c2Lin2 Tonsillar
Plasmacytoid Cells. Next, the surface phenotype of isolated
plasmacytoid cells was analysed by flow cytometry (Fig. 4).
Although CD41CD11c2 cells express CD45RA, indicat-
ing their hematopoietic origin, they lack all the lineage
markers for B cells (CD19, CD21), T cells (CD2, CD3,
TCR, CD8), natural killer cells (CD56 and CD57), mye-
loid cells (CD13 and CD33), monocytes (CD14 and
CD11b), granulocytes (CD16 and CD35), and Langerhans
cells (CD1a). However, they express MHC class II antigens
and the adhesion molecules CD11a, CD18, CD44, and
CD54 (but not CD58). They also express low levels of
CD40 and CD38. They do not express detectable levels of
B7.1/CD80 and B7.2/CD86. This phenotypic profile fits
well with that of the in situ plasmacytoid T cells character-
ized by immunohistochemistry (5). In addition, the pheno-
type of these tonsillar CD41CD11c2Lin2 plasmacytoid
cells is similar to that of the blood CD41CD11c2Lin2 cells,
that differentiate into dendritic cells when cultured with
monocyte-conditioned medium (15).
Plasmacytoid Cells Die Rapidly by Apoptosis when Cultured
in Medium unless Rescued by IL-3. The nature of these
plasmacytoid cells was further analyzed by cell culture with
different cytokines. Strikingly, these cells undergo rapid
spontaneous apoptosis in culture, resulting in 40% of cells
displaying apoptotic figures at 4 h (Fig. 5, B and D) and
.90% at 16 h (Fig. 5 F). Among a wide range of tested cy-
tokines (IL-1a, IL-1b, IL-2, IL-3, IL-4, IL-6, IL-7, IL-10,
M-CSF, GM-CSF, SCF) and CD40-ligand, IL-3 alone was
found to completely block the apoptotic cell death of plas-
macytoid cells (Fig. 5, A and C). In contrast to cells cul-
tured in medium alone, cells cultured with IL-3 rapidly
formed aggregates within 4 h (Fig. 5 A) and few cells dis-
played apoptotic figures (Fig. 5 C). During the next 6 d of
culture with IL-3, .90% of cells remained viable (Fig. 6 A)
and displayed: (a) pseudopods after 16 h of culture (Fig. 5 E);
(b) blastic nuclei and mitotic figures after 3 d of culture
(Fig. 5 G); and (c) veiled morphology after 6 d of culture
(Fig. 5 H). The CD41 plasmacytoid cells cultured for 3 d in
the presence of IL-3 incorporated [3H]thymidine (Fig. 6 B), a
finding consistent with the appearance of mitotic figures at
this stage. Two cytokine combinations (GM-CSF1TNFa
and GM-CSF1IL-4) that, respectively, induce CD341 pro-
genitor cells (13) and blood monocytes (11) to become DC
did not have significant survival (not shown) and prolifera-
tion (Fig. 6 B) effects on plasmacytoid cells. CD40-ligand,
a key survival and activation signal for several cell types
(16–18), including B cells (19, 20) and DC (21), did not in-
terfere with the IL-3–dependent survival of plasmacytoid
cells, but inhibited the IL-3–dependent [3H]thymidine up-
take (Fig. 6 B).
CD40-ligand Together with IL-3 Promotes the Differentiation
of Plasmacytoid Cells into DC, that Express Little CD13,
CD33, and CD1a. As described above, CD40-ligand did
not affect the survival of plasmacytoid cells and consistently
Figure 4. Surface phenotype of isolated CD41CD11c2CD32 plasmacytoid cells analyzed by flow cytometry. Filled histograms represent isotype matched
controls, open histograms represent staining with specific antibodies. Data shown are one representative of six experiments.1106 IL-3–dependent Plasmacytoid Dendritic Cell Precursors
blocked the [3H]thymidine incorporation induced by IL-3.
Most strikingly, CD40-ligand induced the development of
long dendrites on these plasmacytoid cells in the presence
of IL-3. Fig. 7 A shows that after 3 and 6 d of culture,
many clusters of cells with long dendrites appeared. This
culture morphology was similar to that of dendritic cells
generated from CD341 progenitor cells cultured with GM-
CSF1TNFa (13). Indeed, Giemsa staining of cytospin
preparation of plasmacytoid cells cultured for 6 d with IL-3
and CD40-ligand revealed a typical mature dendritic cell
morphology (Fig. 7 B). These observations were further
confirmed by TEM and SEM (Fig. 7, C and D). The cells
Figure 5. CD41CD11c2CD32 plasmacytoid cells undergo rapid apoptosis when cultured in medium, unless rescued by IL-3. (A) Many cell clusters at
4 h of culture with IL-3; (B) Dispersed cells at 4 h of culture in medium alone; (C) Few apoptotic cells within clusters at 4 h of culture with IL-3; (D)
Many apoptotic cells at 4 h of culture in medium alone; (E) Cells display pseudopods at 16 h of culture with IL-3; (F). All cells are dead at 16 h of culture
in medium; (G) Mitotic figures at 3 d of culture with IL-3; (H) cells with pseudopods at 6 d of culture with IL-3. Data shown are one representative of
six experiments. Original magnification: (B) 3200.1107 Grouard et al.
cultured with CD40-ligand and IL-3 developed large den-
drites (like spines of hedgehog) (Fig. 7 C) and did not have
a trace of RER (Fig. 7 D).
The phenotype of plasmacytoid cells cultured for 6 d
with IL-3 or with IL-31CD40-ligand (Fig. 8) was subse-
quently determined by flow cytometry. With IL-3, the ad-
hesion molecule CD58 and the costimulatory molecules
B7.1/CD80 and B7.2/CD86 were induced, and the adhe-
sion molecule CD54, the costimulatory molecule CD40
and MHC class II DR were upregulated. CD40-ligand fur-
ther upregulated the expression of the above molecules.
Antigens specifically expressed by myeloid cells (CD13,
CD33, CD11b, CD14, CD35), B cells (CD21), Langerhans
cells (CD1a), NK cells (CD16), or activated cells (CD25
and CD45RO) were not induced under these two culture
conditions. CD11c, a marker highly expressed by different
subsets of DC appeared to be induced on a fraction of cells.
Dendritic Cells Generated from CD41 Plasmacytoid Cells
Display Poor Phagocytosis or Endocytosis Capacities but Strongly
Stimulate Allogeneic CD41CD45RA1 Naive T Cells. To test
the functional properties of DCs generated from plasmacy-
toid cells cultured with IL-3 or IL-31CD40-ligand, their
antigen processing and presentation capacities were ana-
lyzed. In contrast to DC generated from monocytes with
GM-CSF1IL-4, DC derived from plasmacytoid cells after
6 d of cultures either with IL-3 alone or with IL-3 plus
CD40-ligand did not uptake FITC–dextran as analyzed by
FACSÒ (Fig. 9). In addition, they displayed a poor ability
to phagocytose FITC-latex beads as analyzed by confocal
microscopy and electron microscopy (not shown). More-
over, fresh isolated CD41 plasmacytoid cells also failed to
uptake FITC–dextran during a 40-min culture with FITC–
dextran (not shown). However, DC derived from plasma-
cytoid cells stimulated allogeneic CD41CD45RA1 naive T
cells and were at least as potent as monocyte-derived DC
or CD341 progenitor cell–derived DC (Fig. 10). The cells
with pseudopods generated from plasmacytoid cells after 6 d
of culture with IL-3 also significantly stimulated the prolif-
eration of CD41CD45RA1 naive T cells (Fig. 10).
Discussion
The experiments described in this article demonstrate
that the plasmacytoid T cells, which have long been ob-
served in the T cell areas of peripheral lymphoid tissues,
correspond to CD41CD11c2 blood DC precursors (15).
These cells display six striking features: (a) they have a plas-
macytoid morphology, characterized by well developed
RER and Golgi apparatus, which would normally suggest a
terminally differentiated cell type with an active secretory
function; (b) they die very rapidly by apoptosis in simple
culture medium, consistent with the previous report that
nuclear pyknosis and tingible body macrophages were
found within clusters of plasmacytoid T cells in situ (5) and
suggesting a rapid cell turn over rate; (c) they are found ei-
ther close to the HEV or within the lumen of HEV; this,
together with the identification of CD41CD11c2 blood
DC precursors (15), indicates that the tissue plasmacytoid
DC precursors are blood derived; (d) IL-3 represents the
only cytokine tested so far that maintains their survival and
promotes their proliferation; (e) CD40-ligand promotes
their differentiation into mature DC; (f) the plasmacytoid
cell derived DC display features similar to a subset of tonsil-
lar interdigitating cells (Björck, P., and Y.-J. Liu, unpub-
lished observation), including low expression of myeloid
antigens CD13 and CD33 and poor ability to uptake solu-
ble antigens or to phagocytose particles.
DC represent an heterogeneous population of hemato-
poietic-derived cells that display potent ability to prime na-
ive T cells and to stimulate memory T cells (22). The past
few years have witnessed remarkable advances in the isola-
tion of DC precursors and in the definition of culture con-
ditions allowing the generation of DCs (23, 24). DCs have
been generated from early hematopoietic progenitors that
can be isolated from human and mouse bone marrow (25–
28), thymus (29–32), or human blood/cord blood (12, 13,
33, 34). Hematopoietic progenitors isolated from bone mar-
row were shown to have the potential of becoming den-
dritic cells as well as granulocytes, monocytes, and mac-
Figure 6. IL-3 maintains the viability of CD41CD11c2CD32 plasma-
cytoid cells for up to 6 d. (A) Total numbers of viable cells at day 1, day 3,
and day 6 of culture with medium (open circles), IL-3 (open squares), CD40-
ligand transfected L cells (open triangles), CD40-ligand negative L cells 5
ORIENT (solid squares) and CD40-ligand transfected L cells plus IL-3 (solid
triangles). (B) IL-3 induces [3H]thymidine incorporation by plasmacytoid cells
at day 3 of culture. Data shown are one representative of four experiments.1108 IL-3–dependent Plasmacytoid Dendritic Cell Precursors
rophages (27, 34–36). This together with the fact that
monocytes have the potential to differentiate into both
macrophages and dendritic cells (11, 12, 37) suggests a mye-
loid DC developmental pathway. A critical cytokine for
myeloid DC development was shown to be GM-CSF.
Other factors such as TNFa, IL-4, SCF, and CD40-ligand
were shown to enhance the myeloid DC maturation (23,
24). DC have also been generated from the most immature
thymic T cell precursors or from bone marrow lymphoid
progenitors, which could differentiate into T cells, B cells,
and NK cells (28–32). These experiments suggest a lym-
phoid DC developmental pathway. Interestingly, GM-CSF
does not appear to be required for DC generation from
lymphoid precursors (31). In contrast, IL-3 seems to be one
of the key cytokine required for lymphoid DC develop-
ment (28–31). A recent experiment by Maraskovsky et al.
(38) showed that Flt3L could potently enhance the devel-
opment of both myeloid and lymphoid DCs in mice. The
dependence of CD41CD11c2 plasmacytoid cells on IL-3
but not GM-CSF to differentiate into DCs, which express
relatively low levels of CD13 and CD33 myeloid antigens,
suggests that these plasmacytoid cells may represent lym-
phoid-derived immediate DC precursors.
The capacity of CD40-ligand to promote the differentia-
tion of CD41CD11c2Lin2 plasmacytoid cells into DC is
consistent with the previous reports on the diverse effects
of CD40-ligand on the maturation and function of DCs.
Ligation of CD40 on dendritic cells was shown to trigger
production of high levels of IL-12 (39, 40), enhance T cell
stimulatory capacity (21, 41–43) and improve DC survival
(21, 42, 43). A recent experiment showed that ligation of
CD40 induced a subset of human CD341 hematopoietic
progenitors to proliferate and differentiate into DC (44).
Taken together, these data suggest that T cells play impor-
tant roles in DC generation and maturation.
Tonsillar CD41CD11c2 plasmacytoid cells share many
similar features with the blood CD41CD11c2 (15) or CD33low
CD14low DC precursors (45). However, blood CD41CD11c2
cells appear to survive better than tonsillar CD41CD11c2
cells in culture medium (15, our unpublished observation),
suggesting that the apoptosis program of these cells may be
further triggered upon their arrival within tissues. Blood
CD41CD11c2 cells were shown earlier to differentiate
into DCs in the presence of undefined factors within
monocyte-conditioned medium (15). In our hands, these
blood CD41CD11c2 cells were found to become DCs in the
presence of IL-3 and CD40-ligand (data not shown), as tonsil-
lar CD41CD11c2 cells. This strongly suggests that the ton-
sillar CD41CD11c2 plasmacytoid cells are derived from blood
CD41CD11c2 cells.
Figure 7. CD41CD11c2CD32 plasmacytoid cells acquire the morphology of mature interdigitating dendritic cells after 6 d of culture with IL-3 and
CD40-ligand. (A) Culture morphology; (B) Giemsa staining; (C) SEM; (D) TEM. Original magnification: (A) 3100; (B) 3400; (C) 33,000; (D) 36,000.1109 Grouard et al.
Figure 8. CD41CD11c2CD32 plasmacytoid cells express high levels of costimulatory molecules, but few myeloid antigens, after 6 d of culture with
IL-3 or IL-31CD40-ligand. Filled histograms represent isotype matched controls, open histograms represent staining with specific antibodies. Data
shown are one representative of six experiments.
Figure 9. Dendritic cells derived from CD41CD11c2CD32 plasmacy-
toid cells after 6 d of culture with IL-31CD40-ligand did not uptake
FITC-dextran. Methods are as described by Sallusto et al. (11). Time 0
represents cells that were incubated with FITC–dextran for 30 min at
48C. After three washes, the FITC–dextran uptake by plasmacytoid cells
derived DC cultured with IL-3 (open squares) or with IL-3 plus CD40-
ligand (solid circles) and monocyte-derived DC (solid triangles) at 378C were
analyzed with a FACScanÒ flow cytometer. MFI, mean fluorescence in-
tensity. Data shown are one representative of three experiments.
Figure 10. DC derived from CD41CD11c2CD32 plasmacytoid cells
induces strong proliferation of CD41CD45RA1 naive T cells. Purified
allogeneic blood CD41CD45RA1 naive T cells were cocultured with
different numbers of DC generated from: CD141 monocyte–derived
DCs (solid circle), CD341 progenitor–derived DCs (solid square), plasma-
cytoid cells after 6 d of culture with IL-3 (open square) and plasmacytoid
cells after 6 d of culture with IL-3 and CD40L (open circle). After 5 d of
DC-T cell cocultures, cells were pulsed with 1 mCi [3H]thymidine for 8 h
before harvesting and counting. Data shown are one representative of six
experiments.1110 IL-3–dependent Plasmacytoid Dendritic Cell Precursors
The increased accumulation of CD41CD11c2 plasma-
cytoid cells in the draining lymph nodes of tumor patients
suggests important immunological functions in these patho-
logical conditions. They may be constantly produced in
bone marrow and may migrate through blood to the T cell
areas of the spleen by crossing the marginal zone sinuses or
the T cell areas of lymph nodes or tonsils by crossing the
HEV. There, they would undergo rapid apoptosis, unless
rescued by T cell signals (IL-31CD40-ligand) generated by
on going antigen-driven T cell–dependent immune re-
sponses. Thus, the IL-3 and CD40-ligand–dependent DC
development from plasmacytoid precursors may represent a
unique peripheral regulatory pathway that can rapidly re-
cruit large numbers of DC into immune responses.
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